The progression from NASH to HCC was also reduced by neutralizing OxPLs in AMLN-fed E06-scFv Ldlr−/− compared with Ldlr−/− mice, as indicated by significant reduction in tumor number, tumor volume and tumor incidence. This evidence concerns the gene LDLR and metabolic dysfunction-associated steatohepatitis.